Data / Form D filings / Durin Life Sciences, Inc.
Durin Life Sciences, Inc.: Form D filings
Durin Life Sciences, Inc., a biotechnology company in Stratford, NJ, filed 6 Form D notices with the SEC between 2019 and 2025. The latest, on July 21, 2025, reports $6.2 million sold of a $10 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 MEDICAL CENTER DR #213A, Stratford, NJ, 08084
- Phone
- (877) 387-4657
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1797306
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | Amendment | $10,000,000 | $6,200,000 | $3,800,000 | 2 | Oct 17, 2023 | sec.gov |
| Mar 18, 2025 | Amendment | $5,499,900 | $5,499,900 | 3 | Mar 16, 2021 | sec.gov | |
| Oct 27, 2023 | New notice | $5,000,000 | $3,500,000 | $1,500,000 | 2 | Oct 17, 2023 | sec.gov |
| Jan 9, 2023 | Amendment | $5,499,900 | $4,554,000 | $945,900 | 2 | Mar 16, 2021 | sec.gov |
| Mar 23, 2021 | New notice | $3,500,100 | $3,500,100 | 2 | Mar 16, 2021 | sec.gov | |
| Dec 19, 2019 | New notice | $3,500,100 | $3,500,100 | 2 | Nov 25, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Maribeth Bluyus | Executive Officer | |
| Robert Nagele | Director | |
| Rene Chaze | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Jul 21, 2025 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Durin Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.